Â鶹´«Ã½

News — Scientists from (ACS) are presenting important research studies at this year’s annual meeting of the in Chicago, May 31-June 4, 2024. ASCO is the world’s largest clinical cancer research meeting, attracting an estimated 40,000 oncology professionals from around the world. This year's program will feature more than 5,000 abstracts and 200 sessions complementing the meeting’s theme: “The Art and Science of Cancer Care: From Comfort to Cure.” Below are titles/links for top oral presentations and posters including ACS experts:

Poster Presentations:

June 1, 2024, 9:00am, CDT
(lead)/ (presenter)
ASCO Abstract #1526/Poster Board #397
Substantial cancer underdiagnosis and declines in proportion of early-stage diagnoses continued nationwide in 2021, the second year of the COVID-19 pandemic. However, the pattern was worse in non-expansion states, suggesting a protective effect of Medicaid expansion on cancer early diagnosis during the public health emergency. Findings may inform policy makers and the public in the 10 states that have yet to expand Medicaid eligibility.

Read more here: 
June 1, 2024, 9:00am, CDT
ASCO Abstract #1580/Poster Board #451
ASCO Conquer Cancer Merit award The introduction of Immune Checkpoint Inhibitors increased disparities in survival by health insurance status. Policies to improve health insurance coverage options or make new treatments more affordable to uninsured patients are needed.

Read more here:  June 3, 2024, 1:30pm, CDT
ASCO Abstract #10541/Poster Board #68
Adherence to physical activity recommendations for cancer prevention could significantly lower the risk of developing cancers, including those related to obesity.

Read more here: June 3, 2024, 1:30pm, CDT
ASCO Abstract #12043/Poster Board #172
Older adult cancer survivors who were overweight or obese at the time of their first cancer diagnosis were shown to be at higher risk of developing a second cancer, especially a BMI-related cancer. These findings have important public health implications given the high prevalence of overweight and obesity in this population. Weight loss strategies should be considered and heightened awareness of second cancers among physicians of older cancer survivors.

Read more here:

Oral Presentations:


June 3, 2024, 2:27pm, CDT
Dr. Xin Hu
ASCO Abstract #11017 (Rapid Oral)
Despite considerable growth in early palliative care receipt, utilization remained low in 2019. The large variation between providers and organizations suggests important modifiable provider behaviors and organizational characteristics in early PC use, which warrant future research.

Read More Here:

Online publication only:

ASCO Abstract #e23170
Researchers stress women and less active participants may be particularly at risk, suggesting that targeted interventions to reduce social isolation in these populations may be warranted.

For more information and to set up interviews, contact [email protected].

Follow ASC researchers at the meeting on X/Twitter at @AmericanCancer @ACS_Research @ACSÂ鶹´«Ã½.

                                                                             # # #

About the American Cancer Society
The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit  or call our 24/7 helpline at 1-800-227-2345. Connect with us on , , and .